Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 344

    Alembic Pharma gets USFDA approval for bladder drug

    Alembic Pharma gets USFDA approval for bladder drug

    Ruby Khatun Khatun13 Dec 2017 11:00 AM IST
    New Delhi: Alembic Pharmaceuticals has received US health regulator's nod for a drug used to treat overactive bladder with symptoms of urinary...
    Apollo Pharmacy misappropriation case: CBI carries out searches in BEL hospital

    Apollo Pharmacy misappropriation case: CBI carries out searches in BEL hospital

    Ruby Khatun Khatun13 Dec 2017 10:40 AM IST
    New Delhi: The CBI has carried out searches at three locations in Bengaluru in connection with alleged misappropriation of over Rs 44 lakh by an...
    Apollo Munich eyes 30 percent growth in FY18 premium collection

    Apollo Munich eyes 30 percent growth in FY18 premium collection

    Ruby Khatun Khatun13 Dec 2017 10:15 AM IST
    HYDERABAD: Apollo Munich Health Insurance said it expects 30 percent growth in the premium collection to Rs 1,700 crore by the end of the current...
    Amgens Kyprolis improves overall survival in blood cancer patients

    Amgen's Kyprolis improves overall survival in blood cancer patients

    Ruby Khatun Khatun13 Dec 2017 10:00 AM IST
    Amgen Inc said on Monday a final analysis of late-stage trial data showed that its Kyprolis combined with two other drugs helped blood cancer patients...
    Roche: Tecentriq cocktail slows kidney cancer progression

    Roche: Tecentriq cocktail slows kidney cancer progression

    Ruby Khatun Khatun13 Dec 2017 9:45 AM IST
    ZURICH: Combining Roche’s Tecentriq immunotherapy with its older drug Avastin for the initial treatment of advanced kidney cancer reduced the risk of...
    Philippine senator criticizes reckless disregard in dengue vaccine program

    Philippine senator criticizes reckless disregard in dengue vaccine program

    Ruby Khatun Khatun13 Dec 2017 9:30 AM IST
    MANILA: Philippine public officials showed “reckless disregard of processes” in carrying out a program to immunize hundreds of thousands of children,...
    Suven gets product patents from India, US

    Suven gets product patents from India, US

    Ruby Khatun Khatun12 Dec 2017 11:00 AM IST
    New Delhi: Suven Life Sciences has secured a product patent each from India and the US for treatment of disorders associated with neurodegenerative...
    Alembic Pharma associate co gets USFDA fast track designation for cancer drug

    Alembic Pharma associate co gets USFDA fast track designation for cancer drug

    Ruby Khatun Khatun12 Dec 2017 10:45 AM IST
    New Delhi: Drug firm Alembic Pharmaceuticals said the US health regulator has granted fast track designation to its associate company Rhizen...
    Granules arm completes audit with USFDA

    Granules' arm completes audit with USFDA

    Ruby Khatun Khatun12 Dec 2017 10:30 AM IST
    New Delhi: Pharma firm Granules India said its US subsidiary has received an observation from the USFDA on completion of the inspection."Granules...
    Roche lymphoma drug drives high remission rate, longer survival: study

    Roche lymphoma drug drives high remission rate, longer survival: study

    Ruby Khatun Khatun12 Dec 2017 10:00 AM IST
    An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced,...
    Bill Gates acknowledges Hester for developing a Newcastle Disease Vaccine

    Bill Gates acknowledges Hester for developing a Newcastle Disease Vaccine

    Ruby Khatun Khatun12 Dec 2017 9:45 AM IST
    Bill Gates mentioned Hester’s name in his speech at AP AgTech Summit 2017 in Visakhapatnam on 17 November 2017.Gates referred to the Bill &...
    Zydus gets USFDA nod for schizophrenia drug

    Zydus gets USFDA nod for schizophrenia drug

    Ruby Khatun Khatun11 Dec 2017 11:00 AM IST
    New Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clozapine tablets, used in the treatment...
    PrevNext

    Popular Stories

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok